City of Industry, CA --(www.USEquityNews.com)-- 11/08/2007 - Biotechnology industry alert provided by U.S. Equity News.
Gilead Sciences Inc. and LG Life Sciences Ltd. said recently they entered a license agreement focused on caspase inhibitors for the treatment of fibrotic diseases. Foster City-based Gilead (NASDAQ: GILD) and Seoul, Korea-based LG did not disclose financial details. The agreement grants Gilead commercialization rights to LGLS' caspase inhibitors, including an investigational pan-caspase inhibitor currently being evaluated in a Phase IIa clinical trial in patients chronically infected with the hepatitis C virus.

ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel cancer therapeutics, recently announced that the Company is scheduled to present at the Bear Stearns 2007 SMid-Cap Conference in New York, NY on Wednesday, November 14, 2007 at 10:00 a.m. EST. A corporate overview will be provided, including additional information on the Company’s product portfolio. The presentation will be webcast live and may be accessed by visiting ImClone Systems’ website at www.imclone.com.

Celgene Corporation (NASDAQ: CELG) announced recently that its presentation at the Credit Suisse Annual Healthcare Conference on Tuesday, November 13, 2007 at 2:00 pm MST (12:00 pm EST) will be webcast live and will be available in the investor relations section of the Company's website at www.celgene.com. David W. Gryska, Senior Vice President and Chief Financial Officer will provide an overview of the company. Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation.

Emergency Disaster Systems, Inc., a subsidiary of U.S. BioDefense, Inc. (OTCBB: UBDE) assists Certified Emergency Response Teams (CERT) in California by donating supplies. These supplies include emergency blankets, disposable gloves and dust masks. All CERT groups that have not been notified can contact Emergency Disaster Systems by calling (866) MyEDSkit or email cs@myedskit.com to receive their supplies. "We would like to support all fire departments, CERT, and volunteers that are assisting the victims of this tragic event," said David Chin, CEO of U.S. BioDefense.

About U.S. Equity News

U.S. Equity News provides information, resources and news services for investors of small-cap, micro-cap and emerging companies. U.S. Equity News distributes RSS news feeds and a free subscription-based newsletter available through its website at www.usequitynews.com.

U.S. Equity News is a financial news distribution service by Equity Solutions, Inc. (www.equityirsolutions.com) that provides a platform for public companies to disseminate important news to key Wall Street interest such as shareholders and new investors. Equity Solutions, Inc. can assist by providing an effective increase in the awareness of a public company's news, development and corporate story through its proprietary network and its financial portal. U.S. Equity News and its affiliates charge each client cash for news distribution and may take an equity position in the companies mentioned herein, please visit the disclaimer at www.USEquityNews.com

Contact Information:
U.S. Equity News
Tel: (626) 961-8039
Email: info@usequitynews.com

EMAIL THIS RELEASE
Your Name:
From Email:
To Email:
Message: